Biosimilars: Patient and Physician Acceptability is the Fifth Hurdle to Market Competition

Author/Creator

Author/Creator ORCID

Date

2015

Department

Program

Citation of Original Publication

Lyles, A., (2015). Biosimilars: Patient and Physician Acceptability is the Fifth Hurdle to Market Competition. Generics and Biosimilars Initiative Journal. 4(1). DOI: 10.5639/gabij.2015.0401.002.

Rights

Abstract

Biosimilar products confront novel market authorization and post-marketing use hurdles. Existing evidence is insufficient to fully address physician and payer acceptability thresholds.